Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Calcium and vitamin D supplementation appeared to attenuate but not eliminate the adverse effects, with supplemented patients showing smaller but still significant differences in bone loss compared to unsupplemented intranasal corticosteroid users (interaction p = 0.089).

Source: Subgroup analyses. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cohort study.

Cohort study

Examines exposures and outcomes over time within a defined group.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study

Source: Article title.

Participants were categorized into INCS (n = 198), second-generation antihistamine (sgAH, n = 187), combination therapy (n = 156), and control (n = 150) groups.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Long-term intranasal corticosteroids vs. antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study

Cohort study · Frontiers in Medicine · 2026

Original publication title

Long-term intranasal corticosteroids vs. antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study

Xiaofei Jia; Lei Liu; Yanzhong Yang

Copyright © 2026 Jia, Liu and Yang.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Long-term INCS use in post-menopausal women was associated with accelerated bone loss, increased osteoporosis risk, and higher fracture rates in a dose-dependent manner. These findings raise concerns regarding the assumption of complete INCS skeletal safety in post-menopausal women and suggest the need for enhanced bone monitoring in this population.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Intranasal corticosteroids (INCS) are first-line therapy for allergic rhinitis (AR), but their long-term skeletal safety in post-menopausal women: who are inherently vulnerable to bone loss: remains inadequately studied despite low systemic bioavailability.

Source: Background

Abstract: What methods does the paper describe?

This retrospective cohort study included 691 post-menopausal women with persistent AR treated from 2015 to 2023. Participants were categorized into INCS (n = 198), second-generation antihistamine (sgAH, n = 187), combination therapy (n = 156), and control (n = 150) groups. Primary outcomes were changes in bone mineral density (BMD) T-scores and incident osteoporosis. Secondary outcomes included fragility fractures. Multivariable regression analyses were performed with adjustment for confounders, and dose-response relationships were evaluated using defined daily doses.

Source: Methods

Abstract: Results

Over a median follow-up of 4.2 years, INCS users exhibited significantly greater declines in lumbar spine T-scores compared to controls, with similar findings at the femoral neck. sgAH users showed no significant bone loss. Dose-response analysis revealed linear trends for greater bone loss with higher cumulative INCS exposure. Incident osteoporosis occurred in 24.2% of INCS users vs. 11.3% of controls. Fragility fracture rates were highest in the INCS group with adjusted HR 3.85 (95% CI = 1.45 to 10.24, p = 0.007) vs. controls. sgAH showed no increased fracture risk (HR 1.13, 95% CI = 0.33 to 3.89).

Subgroup analyses identified heightened risk in women aged ≥65 years and those with BMI < 23 kg/m2.

Source: Results

Abstract: Conclusions

Long-term INCS use in post-menopausal women was associated with accelerated bone loss, increased osteoporosis risk, and higher fracture rates in a dose-dependent manner. These findings raise concerns regarding the assumption of complete INCS skeletal safety in post-menopausal women and suggest the need for enhanced bone monitoring in this population.

Source: Conclusions
Authors’ abstract

Background

Intranasal corticosteroids (INCS) are first-line therapy for allergic rhinitis (AR), but their long-term skeletal safety in post-menopausal women: who are inherently vulnerable to bone loss: remains inadequately studied despite low systemic bioavailability.

Methods

This retrospective cohort study included 691 post-menopausal women with persistent AR treated from 2015 to 2023. Participants were categorized into INCS (n = 198), second-generation antihistamine (sgAH, n = 187), combination therapy (n = 156), and control (n = 150) groups. Primary outcomes were changes in bone mineral density (BMD) T-scores and incident osteoporosis. Secondary outcomes included fragility fractures. Multivariable regression analyses were performed with adjustment for confounders, and dose-response relationships were evaluated using defined daily doses.

Results

Over a median follow-up of 4.2 years, INCS users exhibited significantly greater declines in lumbar spine T-scores compared to controls, with similar findings at the femoral neck. sgAH users showed no significant bone loss. Dose-response analysis revealed linear trends for greater bone loss with higher cumulative INCS exposure. Incident osteoporosis occurred in 24.2% of INCS users vs. 11.3% of controls. Fragility fracture rates were highest in the INCS group with adjusted HR 3.85 (95% CI = 1.45 to 10.24, p = 0.007) vs. controls. sgAH showed no increased fracture risk (HR 1.13, 95% CI = 0.33 to 3.89).

Subgroup analyses identified heightened risk in women aged ≥65 years and those with BMI < 23 kg/m2.

Conclusions

Long-term INCS use in post-menopausal women was associated with accelerated bone loss, increased osteoporosis risk, and higher fracture rates in a dose-dependent manner. These findings raise concerns regarding the assumption of complete INCS skeletal safety in post-menopausal women and suggest the need for enhanced bone monitoring in this population.

Publication and source details

Original title: Long-term intranasal corticosteroids vs. antihistamines and bone health in post-menopausal women with allergic rhinitis: a retrospective cohort study

Xiaofei Jia; Lei Liu; Yanzhong Yang

Frontiers in Medicine · 2026

* Correspondence: Xiaofei Jia, eyjxffei@163.comCopyright © 2026 Jia, Liu and Yang.2026Jia, Liu and Yanghttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was not received for this work and/or its publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:56:43.742079+00:00

DOI: 10.3389/fmed.2026.1838641 · PMC13500620